Upcoming Events
Stay connected with the latest conversations and learning opportunities from CDPC. Our upcoming events bring together experts and communities from across movements to explore key issues and connections in drug policy.
Perspectives on 10 Years in Crisis: The Power and Limits of Evidence in Policy Change with Lisa Lapointe
Join us for an in-depth conversation to explore how Lapointe’s perspective on the unregulated drug crisis evolved in her role, the tension between evidence-informed expert recommendations and government policy choices, and the importance of data transparency.
Previous Events
Explore our archive of past events to watch recordings and learn more.
Solidarity Not Silos: The Attack on Public Healthcare
Across Canada, marginalized communities are being blamed for crises caused by political choices to underfund healthcare and other essential services. We confront these escalating threats, strengthen cross-movement solidarity, and share actionable solutions.
Confronting Fear-Based Politics – Drug Policy, Borders and Migration
Examine how drug policy and migration intersect, revealing how fear-driven politics and criminalization harm marginalized communities and undermine human rights.
HIV/AIDS, Harm Reduction and 2SLGBTQIA+ History
Explore the intertwined histories of the HIV/AIDS epidemic and harm reduction, and learn how past and present organizers continue to defend health, dignity, and justice today.
Beyond the Distractions: Criminalization Across Communities
Examine decriminalization across movements, uncovering shared histories, lived experiences, and the power of solidarity in advancing human rights for all.
Shared Struggles, Shared Rights: Building Solidarity for Bodily Autonomy
Explore the intersections of bodily autonomy, drug policy, reproductive rights, mental health, and trans rights—and discover how collective action drives justice and freedom.
Getting to Tomorrow: 7 Actions to End the Unregulated Drug Crisis
This project brought together communities across Canada to identify seven key action areas and 82 recommendations for drug policies that promote safety, equity, and well-being for all.